Gene, cell, and RNA therapy startup financing quarterly 2022
This statistic shows the quarterly start-up financing for gene, cell, and RNA therapy companies from Q4 2021 to Q4 2022. Start-up financing in Q4 2022 involving gene, cell, and RNA therapy companies stood at some 310 million U.S. dollars, the lowest amount in the provided period.